(Q42951068)

11 November 2017

title

Design, synthesis, and cholesterol-lowering efficacy for prodrugs of berberrubine (English)

1 reference

11 November 2017

3

Peng Yang

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20673726

14 June 2024

7

Hong-Bin Deng

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20673726

14 June 2024

author name string

Ying-Hong Li

1

1 reference

11 November 2017

Yi Li

2

1 reference

11 November 2017

Wei-Jia Kong

4

1 reference

11 November 2017

Xue-Fu You

5

1 reference

11 November 2017

Gang Ren

6

1 reference

11 November 2017

Yue-Ming Wang

8

1 reference

11 November 2017

Yan-Xiang Wang

9

1 reference

11 November 2017

Jian-Dong Jiang

10

1 reference

11 November 2017

Dan-Qing Song

11

1 reference

11 November 2017

language of work or name

English

0 references

publication date

30 July 2010

1 reference

full work available at URL

11 November 2017

https://api.elsevier.com/content/article/PII:S0968089610006346?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.BMC.2010.06.106

https://api.elsevier.com/content/article/PII:S0968089610006346?httpAccept=text/plain

14 June 2024

1 reference

https://api.crossref.org/works/10.1016/J.BMC.2010.06.106

Bioorganic & Medicinal Chemistry

14 June 2024

published in

1 reference

11 November 2017

volume

18

1 reference

11 November 2017

issue

17

1 reference

11 November 2017

page(s)

6422-6428

1 reference

Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins

11 November 2017

cites work

3

1 reference

https://api.crossref.org/works/10.1016/J.BMC.2010.06.106

Combination of simvastatin with berberine improves the lipid-lowering efficacy

14 June 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.BMC.2010.06.106

Reduction of blood lipid by berberine in hyperlipidemic patients with chronic hepatitis or liver cirrhosis

14 June 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.BMC.2010.06.106

Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine

14 June 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.BMC.2010.06.106

Efficacy of berberine in patients with type 2 diabetes mellitus

14 June 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.BMC.2010.06.106

Human low-density lipoprotein receptor gene and its regulation

14 June 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.BMC.2010.06.106

Extracellular signal-regulated kinase-dependent stabilization of hepatic low-density lipoprotein receptor mRNA by herbal medicine berberine

14 June 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.BMC.2010.06.106

Synthesis and structure-activity relationships of berberine analogues as a novel class of low-density-lipoprotein receptor up-regulators

14 June 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.BMC.2010.06.106

Synthesis and biological evaluation of berberine analogues as novel up-regulators for both low-density-lipoprotein receptor and insulin receptor

14 June 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.BMC.2010.06.106

Berberine analogues as a novel class of the low-density-lipoprotein receptor up-regulators: synthesis, structure-activity relationships, and cholesterol-lowering efficacy

14 June 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.BMC.2010.06.106

Pharmacokinetics of berberine and its main metabolites in conventional and pseudo germ-free rats determined by liquid chromatography/ion trap mass spectrometry.

14 June 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.BMC.2010.06.106

Isolation and identification of urinary metabolites of berberine in rats and humans

14 June 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.BMC.2010.06.106

Antimicrobial activity of 9-O-acyl- and 9-O-benzoyl-substituted berberrubines

14 June 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.BMC.2010.06.106

Design of ester prodrugs to enhance oral absorption of poorly permeable compounds: challenges to the discovery scientist

14 June 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.BMC.2010.06.106

14 June 2024

Identifiers

1 reference

11 November 2017

1 reference